Unknown

Dataset Information

Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis.


ABSTRACT:

Introduction

Coronavirus disease 2019 (COVID-19) is increasing worldwide, with complications due to frequent viral mutations, an intricate pathophysiology, and variable host immune responses. Biomarkers with predictive and prognostic value are crucial but lacking.

Methods

Serum samples from authentic and D614G variant (non-Omicron), and Omicron-SARS-CoV-2 infected patients were collected for METRNβ detection and longitudinal cytokine/chemokine analysis. Correlation analyses were performed to compare the relationships between serum METRNβ levels and cytokines/chemokines, laboratory parameters, and disease severity. Receiver operating characteristic (ROC) curves and Kaplan-Meier survival curves were used to evaluate the predictive value of METRNβ in COVID-19.

Results

Th

SUBMITTER: Gao X 

PROVIDER: S-EPMC9927217 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature